Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2024 07:30 ET | Source: GURU Organic Energy Corp.

GURU Organic Energy fait son entrée dans le segment sans sucre avec GURU Zéro Baies sauvages qui boost le métabolisme

ZÉRO SUCRE : le segment des boissons énergisantes qui connaît la plus forte croissance au Québec1 et aux États-Unis2, alors que plus de consommateurs recherchent des boissons énergisantes à faible...
May 02, 2024 07:30 ET | Source: GURU Organic Energy Corp.

GURU Organic Energy Enters Zero Sugar Segment With Metabolism-Boosting GURU Zero Wild Berry

ZERO SUGAR: fastest growing energy drink segment in Quebec1 and the US2 as more consumers seek low-calorie, sugar-free energy drinks.METABOLISM BOOST: EGCG and catechins, a form of green tea...
February 02, 2024 07:46 ET | Source: Research and Markets

Catechin Market Poised for Growth: Insights on Trends and Outlook Unveiled in New Global Research Report (2024-2031)

Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Catechin Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to...
May 22, 2023 11:03 ET | Source: Research and Markets

Global Catechin Market Report 2023: Increasing Awareness of Health Benefits Drives Growth

Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Global Catechin Market Size, Trends, By Source, By Application, and By Region: Global Opportunity Analysis and Industry Forecast, 2023-2030" report has...
February 15, 2022 09:00 ET | Source: Allied Market Research

Global catechin market to reach $21.09 million by 2030: Allied Market Research

Portland, OR, Feb. 15, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global catechin market generated $14.82 million in 2020, and is estimated to reach...
October 21, 2014 09:00 ET | Source: Plandai Biotechnology, Inc.

Plandai Biotechnology's Technology Could Prove Potent in Battling Alzheimers Disease

NEW YORK, NY--(Marketwired - October 21, 2014) - In the recently released preliminary results from Plandaí Biotechnology's (OTCQB: PLPL) human clinical trial that compared its green tea extract to a...